Skip to main navigation

Theratechnologies Announces Completion of Acquisition by Future Pak. Click here to learn more.

Theratechnologies Inc. Theratechnologies Inc.

    About

  • About
    • About Us
  • Medicines & Pipeline

  • Medicines & Pipeline
    • Medicines
      • Trogarzo®
      • EGRIFTA SV®/WR™
    • Pipeline & Science
      • HIV
        • Scientific Papers
        • Patient Information
      • Expanded Access Policy
      • Grants/ISRs/IITs
  • IR Nav

  • News
  • Compliance, Ethics & Privacy

  • Compliance, Ethics & Privacy
    • Compliance
      • California Declaration
      • Report on Modern Slavery
    • Ethics
      • Code of Business Conduct and Ethics
      • Anti-Bribery and Corruption Policy
    • Privacy
  • Careers

  • Careers
  • Contact Us

  • Contact Us
  • en
    • en
    • fr
  • btn Alerts

  • Sign up for Email Alerts

Social icons

HIV Scientific Papers

HIV Scientific Papers

Pulmonary delivery of TH9507, a growth hormone releasing factor analogue, in the dog.
2004
Int J Pharm.
Jansen M, Darby I, Abribat T, et al.
276(1-2):75-81.
Learn more
  • First page «
  • Previous page ‹
  • …
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Current page 28

Headquarters

Theratechnologies inc.
2015 Peel Street, 11th Floor
Montréal, Québec
Canada H3A 1T8
Phone: 514 336-7800
Fax: 514 331-9691

Privacy

Jocelyn Lafond
Privacy Officer
privacy@theratech.com

US Headquarters

Theratechnologies U.S., Inc.
101 Hudson Street
21st Floor
Jersey City, New Jersey 07302

Main Nav

  • Home
  • About
  • Medicines & Pipeline
  • News
  • Compliance, Ethics and Privacy
  • CA Disclosure
  • Careers
  • Contact Us
©2026 - Theratechnologies Inc.

Legal Nav

  • Terms of Use
  • Privacy

Search

Theratechnologies